文献速递糖尿病

二羰基应激与补体激活的关联:CODAM研究

Associations of dicarbonyl stress with complement activation: the CODAM study.
PubMed 文献 · Diabetologia · 2020-01-28

在CODAM队列530名参与者中,探讨二羰基应激标志物与补体激活产物C3a和sC5b-9的关联。调整混杂因素后,GO与sC5b-9呈负相关,蛋白结合型CEL与C3a呈负相关,而蛋白结合型戊糖苷与sC5b-9呈正相关;GLO1 rs1049346 AG和AA基因型者sC5b-9较低。

要点

  • 血浆GO与sC5b-9呈负相关(β -0.12),蛋白结合型CEL与C3a呈负相关(β -0.17)。
  • 蛋白结合型戊糖苷与sC5b-9呈正相关(β 0.15),其他标志物无显著关联。
  • GLO1 rs1049346 AG和AA基因型者sC5b-9较GG基因型分别低0.32和0.40个标准差。

核心结论

  • 二羰基应激标志物与补体激活产物呈现不同的关联:部分标志物与C3a或sC5b-9呈负相关,而蛋白结合型戊糖苷与sC5b-9持续正相关。
  • 这提示单个二羰基应激标志物与补体激活之间存在不同的生物学关系。

研究设计与样本

  • 研究为人类队列研究,纳入Cohort on Diabetes and Atherosclerosis Maastricht(CODAM)研究的530名参与者,平均年龄59.5±7.0岁(均值±标准差),男性占61%。
  • 测量循环中二羰基应激标志物(α-二羰基化合物MGO、GO、3-DG;游离AGEs CML、CEL、MG-H1;蛋白结合型AGEs CML、CEL、戊糖苷)及补体激活产物C3a和sC5b-9。
  • 采用多元线性回归分析二羰基应激(标准化)与补体激活(标准化)的关联,并调整年龄、性别、生活方式、用药及肥胖标志物等潜在混杂因素。
  • 评估GLO1基因两个潜在功能多态性(rs1049346、rs2736654)与C3a和sC5b-9(均标准化)的关联。

主要发现

  • 调整潜在混杂因素后,血浆GO浓度与sC5b-9呈负相关(β -0.12 [95% CI -0.21, -0.02])。
  • 蛋白结合型AGE CEL与C3a呈负相关(β -0.17 [95% CI -0.25, -0.08])。
  • 蛋白结合型AGE戊糖苷与sC5b-9呈正相关(β 0.15 [95% CI 0.05, 0.24])。
  • 其他α-二羰基化合物及其他游离或蛋白结合型AGEs与C3a或sC5b-9均无显著关联。
  • rs1049346 AG和AA基因型个体血浆sC5b-9平均较GG基因型者分别低0.32和0.40个标准差,而C3a浓度在rs1049346各基因型间无显著差异;GLO1 rs2736654与C3a或sC5b-9均无关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Reactive α-dicarbonyl compounds are major precursors of AGEs and may lead to glycation of circulating and/or cell-associated complement regulators. Glycation of complement regulatory proteins can influence their capacity to inhibit complement activation. We investigated, in a human cohort, whether greater dicarbonyl stress was associated with more complement activation. METHODS: Circulating concentrations of dicarbonyl stress markers, i.e. α-dicarbonyls (methylglyoxal [MGO], glyoxal [GO] and 3-deoxyglucosone [3-DG]), and free AGEs (Nε-(carboxymethyl)lysine [CML], Nε-(carboxyethyl)lysine [CEL] and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine [MG-H1]), and protein-bound AGEs (CML, CEL, pentosidine), as well as the complement activation products C3a and soluble C5b-9 (sC5b-9), were measured in 530 participants (59.5 ± 7.0 years [mean ± SD], 61% men) of the Cohort on Diabetes and Atherosclerosis Maastricht (CODAM) study. Multiple linear regression analyses were used to investigate the associations between dicarbonyl stress (standardised) and complement activation (standardised) with adjustment of potential confounders, including age, sex, lifestyle, use of medication and markers of obesity. In addition, the associations of two potentially functional polymorphisms (rs1049346, rs2736654) in the gene encoding glyoxalase 1 (GLO1), the rate-limiting detoxifying enzyme for MGO, with C3a and sC5b-9 (all standardized) were evaluated. RESULTS: After adjustment for potential confounders, plasma concentration of the dicarbonyl GO was inversely associated with sC5b-9 (β -0.12 [95% CI -0.21, -0.02]) and the protein-bound AGE CEL was inversely associated with C3a (-0.17 [-0.25, -0.08]). In contrast, the protein-bound AGE pentosidine was positively associated with sC5b-9 (0.15 [0.05, 0.24]). No associations were observed for other α-dicarbonyls and other free or protein-bound AGEs with C3a or sC5b-9. Individuals with the AG and AA genotype of rs1049346 had, on average, 0.32 and 0.40 SD lower plasma concentrations of sC5b-9 than those with the GG genotype, while concentrations of C3a did not differ significantly between rs1049346 genotypes. GLO1 rs2736654 was not associated with either C3a or sC5b-9. CONCLUSIONS/INTERPRETATION: Plasma concentrations of dicarbonyl stress markers showed distinct associations with complement activation products: some of them were inversely associated with either C3a or sC5b-9, while protein-bound pentosidine was consistently and positively associated with sC5b-9. This suggests different biological relationships of individual dicarbonyl stress markers with complement activation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Xin Y, Hertle E, van der Kallen CJH, et al. Associations of dicarbonyl stress with complement activation: the CODAM study. Diabetologia. 2020. PMID: 31993713. doi:10.1007/s00125-020-05098-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。